Evaxion Biotech (EVAX) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

EVAX Evaxion Biotech

Watchlist

1.370
-0.030-2.14%

Close Nov 21 16:00 ET

8.04MMarket Cap-489P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Evaxion Biotech Offering Up to 5.25M ADSs
Dow JonesNov 18 17:15 ET
ADRs End Lower; Evaxion Biotech A/S Declines 26%
Dow JonesNov 13 16:31 ET
Express News | Evaxion Biotech Shares Are Trading Lower After the Company Received a Nasdaq Delisting Notification
BenzingaNov 13 11:54 ET
European Equities Traded in the US as American Depositary Fall in Wednesday Trading
MT NewswiresNov 13 10:59 ET
Evaxion Biotech Plans Strategic Capital Increase
TipRanksNov 13 08:00 ET
Evaxion Receives and Appeals Delisting Determination From Nasdaq, Remains Committed to Nasdaq Listing
GlobeNewswireNov 13 08:00 ET

Comments

Jaguar8

Nov 14 14:34

13G

$Evaxion Biotech (EVAX.US)$
Evaxion Biotech | SC 13G: Statement of acquisition of beneficial ownership by individuals-Armistice Capital, LLC(9.99%),Steven Boyd(9.99%)
SEC·

Jaguar8

Nov 12 07:01

NEWS

$Evaxion Biotech (EVAX.US)$
Evaxion announces positive preclinical data for cytomegalovirus (CMV) vaccine program EVX-V1
New preclinical data demonstrates that CMV antigens identified with Evaxion's AI-Immunology™ platform trigger targeted immune responses
Results also showcase the successful design of a proprietary prefusion glycoprotein B (gB) antigen with ability to neutralize the virus
Evaxion is advancing these new findings to develop a multi-component CMV vaccine candidate
About 1 in 2...

diligent Anteater_54

Oct 24 13:20

$Evaxion Biotech (EVAX.US)$
Evaxion will attend the largest and most established European meeting on vaccine R&D in Barcelona, Spain, showcasing their AI Immunology platform on October 30th and 31th.

diligent Anteater_54

Oct 22 09:03

$Evaxion Biotech (EVAX.US)$
International Society for Vaccines - ISV 2024, Seoul, South Korea, on day 2 had a super exciting session on AI and machine learning for vaccine R&D. The leaders in the field such as Andreas Holm Mattsson, from EVAXION Biotech A/S, Denmark gave an exciting overview of the AI Immunology platform.

Trytosaveabit

Oct 9 07:12

Hmm! Update

$Evaxion Biotech (EVAX.US)$ Evaxion Says Data From Three Separate Clinical Trials Documents The Ability Of The AI-immunology Platform To Select Clinically Relevant Vaccine Targets

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

EVAX Evaxion Biotech

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target